Immunomedics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Immunomedics and buy or sell other stocks, ETFs, and their options commission-free!About IMMU
Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer.
CEOHarout Semerjian, MBA
CEOHarout Semerjian, MBA
Employees—
Employees—
HeadquartersMorris Plains, New Jersey
HeadquartersMorris Plains, New Jersey
Founded1982
Founded1982
Employees—
Employees—
IMMU Key Statistics
Market cap20.31B
Market cap20.31B
Price-Earnings ratio-51.04
Price-Earnings ratio-51.04
Dividend yield—
Dividend yield—
Average volume5.59M
Average volume5.59M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$87.93
52 Week high$87.93
52 Week low$8.80
52 Week low$8.80
Stock Snapshot
The current Immunomedics(IMMU) stock price is $87.86, with a market capitalization of 20.31B. The stock trades at a price-to-earnings (P/E) ratio of -51.04.
During the trading day, Immunomedics(IMMU) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 5.59M.
The stock's 52-week range extends from a low of $8.80 to a high of $87.93.
The stock's 52-week range extends from a low of $8.80 to a high of $87.93.
People also own
Based on the portfolios of people who own IMMU. This list is generated using Robinhood data, and it’s not a recommendation.